Impact of Severe Sarcopenia on Rehospitalization and Survival One Year After a TAVR Procedure in Patients Aged 75 and Older

References

• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–1011. doi:10.1016/S0140-6736(06)69208-816980116
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791. doi:10.1093/eurheartj/ehx39128886619
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376(14):1321–1331. doi:10.1056/NEJMoa170045628304219
   PubMed Web of Science ®Google Scholar
• Zahn R, Werner N, Gerckens U, et al. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis. Heart. 2017;103(24):1970–1976. doi:10.1136/heartjnl-2016-31100428684438
   PubMed Web of Science ®Google Scholar
• Deeb GM, Reardon MJ, Chetcuti S, et al. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67(22):2565–2574. doi:10.1016/j.jacc.2016.03.50627050187
   PubMed Web of Science ®Google Scholar
• Alfredsson J, Stebbins A, Brennan JM, et al. Gait speed predicts 30-day mortality following transcatheter aortic valve replacement: results from the society of thoracic surgeons/american college of cardiology transcatheter valve therapy registrytm. Circulation. 2016;133(14):1351–1359. doi:10.1161/CIRCULATIONAHA.115.02027926920495
   PubMed Web of Science ®Google Scholar
• Afilalo J, Lauck S, Kim DH, et al. Frailty in older adults undergoing aortic valve replacement: the frailty-avr study. J Am Coll Cardiol. 2017;70(6):689–700. doi:10.1016/j.jacc.2017.06.02428693934
   PubMed Web of Science ®Google Scholar
• Rosenberg I. Epidemiologic and methodologic problems in determining nutritional status of older persons. (Summary comments). Am J Cli Nutr. 1989;50:1231–1233. doi:10.1093/ajcn/50.5.1231
   Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy16930312372
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7. doi:10.1097/MCO.0b013e328333c1c119915458
   PubMed Web of Science ®Google Scholar
• Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging. 2008;12(7):452–456. doi:10.1007/BF298270518615226
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol a Biol Sci Med Sci. 2006;61(10):1059–1064. doi:10.1093/gerona/61.10.105917077199
   PubMed Web of Science ®Google Scholar
• Mamane S, Mullie L, Lok Ok Choo W. Sarcopenia in Older Adults Undergoing Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2019;74(25):3178–3180. doi:10.1016/j.jacc.2019.10.03031856975
   PubMed Web of Science ®Google Scholar
• Bertschi D, Kiss CM, Schoenenberger AW, Stuck AE, Kressig RW. Sarcopenia in patients undergoing transcatheter aortic valve implantation (TAVI): a systematic review of the literature. J Nutr Health Aging. 2021;25(1):64–70. doi:10.1007/s12603-020-1448-733367464
   PubMed Web of Science ®Google Scholar
• Dahya V, Xiao J, Prado CM, et al. Computed tomography-derived skeletal muscle index: a novel predictor of frailty and hospital length of stay after transcatheter aortic valve replacement. Am Heart J. 2016;182:21–27. doi:10.1016/j.ahj.2016.08.01627914496
   PubMed Web of Science ®Google Scholar
• Heidari B, Al-Hijji MA, Moynagh MR, et al. Transcatheter aortic valve replacement outcomes in patients with sarcopenia. EuroIntervention. 2019;15(8):671–677. doi:10.4244/EIJ-D-19-0011031062696
   PubMed Web of Science ®Google Scholar
• Krishnan A, Suarez-Pierre A, Zhou X, et al. Comparing frailty markers in predicting poor outcomes after transcatheter aortic valve replacement. Innovations. 2019;14(1):43–54. doi:10.1177/155698451982769830848712
   PubMedGoogle Scholar
• Nemec U, Heidinger B, Sokas C, Chu L, Eisenberg RL. Diagnosing sarcopenia on thoracic computed tomography: quantitative assessment of skeletal muscle mass in patients undergoing transcatheter aortic valve replacement. Acad Radiol. 2017;24(9):1154–1161. doi:10.1016/j.acra.2017.02.00828365235
   PubMed Web of Science ®Google Scholar
• Mok M, Allende R, Leipsic J, et al. Prognostic value of fat mass and skeletal muscle mass determined by computed tomography in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2016;117(5):828–833. doi:10.1016/j.amjcard.2015.12.01526754122
   PubMed Web of Science ®Google Scholar
• Tokuda T, Yamamoto M, Kagase A, et al. Importance of combined assessment of skeletal muscle mass and density by computed tomography in predicting clinical outcomes after transcatheter aortic valve replacement. Int J Cardiovasc Imaging. 2020;36(5):929–938. doi:10.1007/s10554-020-01776-x32040683
   PubMed Web of Science ®Google Scholar
• Damluji AA, Rodriguez G, Noel T, et al. Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement. Am Heart J. 2020;224:171–181. doi:10.1016/j.ahj.2020.03.02132416332
   PubMed Web of Science ®Google Scholar
• Paknikar R, Friedman J, Cron D, et al. Psoas muscle size as a frailty measure for open and transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016;151(3):745–751. doi:10.1016/j.jtcvs.2015.11.02226896357
   PubMed Web of Science ®Google Scholar
• Garg L, Agrawal S, Pew T, et al. Psoas muscle area as a predictor of outcomes in transcatheter aortic valve implantation. Am J Cardiol. 2017;119(3):457–460. doi:10.1016/j.amjcard.2016.10.01927931723
   PubMed Web of Science ®Google Scholar
• Soud M, Alahdab F, Ho G, et al. Usefulness of skeletal muscle area detected by computed tomography to predict mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis study. Int J Cardiovasc Imaging. 2019;35(6):1141–1147. doi:10.1007/s10554-019-01582-030915667
   PubMed Web of Science ®Google Scholar
• Hebeler KR, Baumgarten H, Squiers JJ, et al. Albumin is predictive of 1-year mortality after transcatheter aortic valve replacement. Ann Thorac Surg. 2018;106(5):1302–1307. doi:10.1016/j.athoracsur.2018.06.02430048632
   PubMed Web of Science ®Google Scholar
• Michel J, Pellegrini C, Rheude T, et al. The clinical impact of psoas muscle cross-sectional area on medium-term mortality after transcatheter aortic valve implantation. Heart Lung Circ. 2020;29(6):904–913. doi:10.1016/j.hlc.2019.05.09531182269
   PubMed Web of Science ®Google Scholar
• Chen L-K, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.01232033882
   PubMed Web of Science ®Google Scholar
• Carey EJ, Lai JC, Sonnenday C, et al. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology. 2019;70(5):1816–1829. doi:10.1002/hep.3082831220351
   PubMed Web of Science ®Google Scholar
• Moisey LL, Mourtzakis M, Cotton BA, et al. Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients. Crit Care. 2013;17(5):R206. doi:10.1186/cc1290124050662
   PubMed Web of Science ®Google Scholar
• Seiji K, Masanori Y, Tetsuro S, et al. Gait speed can predict advanced clinical outcomes in patients who undergo transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10(9):e005088. doi:10.1161/CIRCINTERVENTIONS.117.00508828916601
   PubMed Web of Science ®Google Scholar
• Saji M, Higuchi R, Tobaru T, et al. Impact of frailty markers for unplanned hospital readmission following transcatheter aortic valve implantation. Circ J. 2017;82(8):2191–2198. doi:10.1253/circj.CJ-17-081629311518
   PubMed Web of Science ®Google Scholar
• Conrotto F, D’Ascenzo F, Giordana F, et al. Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry). Am J Cardiol. 2014;113(3):529–534. doi:10.1016/j.amjcard.2013.10.02524315111
   PubMed Web of Science ®Google Scholar
• Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Impact of diabetes mellitus on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2016;117(10):1636–1642. doi:10.1016/j.amjcard.2016.02.04027015888
   PubMed Web of Science ®Google Scholar
• Ando T, Takagi H, Briasoulis A, Umemoto T. Does diabetes mellitus impact prognosis after transcatheter aortic valve implantation? Insights from a meta-analysis. J Cardiol. 2017;70(5):484–490. doi:10.1016/j.jjcc.2017.01.00528601514
   PubMed Web of Science ®Google Scholar
• Arora S, Hendrickson MJ, Strassle PD, et al. Trends in costs and risk factors of 30-day readmissions for transcatheter aortic valve implantation. Am J Cardiol. 2020;137:89–96. doi:10.1016/j.amjcard.2020.09.04132991853
   PubMed Web of Science ®Google Scholar
• Sanchez CE, Hermiller JB, Pinto DS, et al. Predictors and risk calculator of early unplanned hospital readmission following contemporary self-expanding transcatheter aortic valve replacement from the STS/ACC TVT Registry. Cardiovasc Revascularization Med. 2020;21(3):263–270. doi:10.1016/j.carrev.2019.05.032
   Web of Science ®Google Scholar